^
    10ms
    Molecular and clinical portrait of HER2-low invasive lobular carcinomas. (PubMed, Mod Pathol)
    In conclusion, HER2-low ILCs exhibit their own particularities, both on clinical-pathological and molecular levels. Our findings call for larger multicenter validation studies.
    Journal
    |
    HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3)
    |
    HER-2 positive • HER-2 overexpression • HER-2 negative • ERBB3 mutation • ERBB3-L